(Q43837282)

English

Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

S P Jagdev

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Purohit

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Heatley

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C Herling

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R E Coleman

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1433-1438

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous pamidronate for metastatic bone pain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of daily etidronate on the osteolysis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Markers of bone resorption in patients treated with pamidronate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical prediction of response of bone metastases to treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of bisphosphonates in cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012506426440

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1012506426440

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43837282&oldid=2103767863"